Monday, August 25, 2025

Latest

Trulieve: Canaccord Reiterates $97 Price Target Following First Quarter Results

Trulieve Cannabis (CSE: TRUL) reported its first-quarter financial results on May 13th, beating the analyst consensus. The company reported quarterly revenues of $193.8 million, a 15.1% increase sequentially, and a 102% growth year over year. The company reported gross margins of ~70%, with an operating margin of 37.4%. Earnings per share came in at $0.24, with a 15.5% net margin. Adjusted EBITDA came in at $90.8 million.

A few analysts have changed their 12-month price target on Trulieve after the earnings, bringing the mean 12-month price target slightly lower to C$87.38 from $88.08 before the earnings. The street high comes from Stifel-GMP with a C$132 price target while Cantor Fitzgerald has the lowest target price at $62.25.

In Canaccord’s note, their analyst Matt Bottomley reiterates their C$97 price target and speculative buy rating after the earnings, calling the earnings a strong quarter for Top-line and EBITDA growth. Below you can see how Trulieve stood up against Canaccord Genuity’s estimates.

Bottomley says that this 15% growth was all organic, stemming from Trulieve’s key state Florida as same-store sales increased 39% during this quarter. He also notes that the company has seen an acceleration in new patients with the average new customers per week jumping from 4,800 to >6,000 new customers per week.

This quarter also was the first full quarter of Pennsylvania operations, which could have been the reason for the very slight gross margin compression Bottomley says. Trulieve is in the wholesale business which gets lower margins than a fully integrated operation.

As for Trulieve’s outlook, Bottomley seems to think it’s pretty bright saying that adjusted EBITDA coming in at 47% is very high and he believes that they will stay high. On the Harvest acquisition he writes, “in our view, adding a market leadership position in one of the fastest-growing states in the US in Arizona and a deeper presence in Pennsylvania, among other state exposure.”

Below you can see the updated 2021 and 2022 estimates for Trulieve.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

First Majestic Q2 Earnings: Another Record Quarter

Sandstorm Gold Fades Into Royal Gold Merger

Equinox Gold Q2 Earnings: Back On Track

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Tesla: Consensus Earnings Expectations For Q2

Tesla (NASDAQ: TSLA) will be reporting their second quarter financial results on July 26th after...

Sunday, July 25, 2021, 11:33:00 AM

SSR Mining: BMO Lowers Price Target Due To Rising Costs

On January 31st, SSR Mining Inc. (TSX: SSRM) announced full-year 2021 production, a three-year outlook,...

Friday, February 4, 2022, 04:21:00 PM

SLANG Worldwide: Canaccord Raises FY2020 Revenue Estimates Following Q2 Earnings

SLANG Worldwide (CSE: SLNG) announced their second-quarter financials yesterday, with revenue coming in at $4.6...

Friday, August 28, 2020, 01:48:00 PM

Aurora Cannabis: Analysts Slash Price Targets Ahead Of Q4 Earnings

Tomorrow after market close Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be reporting their fiscal...

Monday, September 21, 2020, 03:15:54 PM

US Cannabis: Earnings Preview For The Oncoming Fourth Quarter Results

March is turning out to be a busy month in public cannabis, with many of...

Monday, March 8, 2021, 04:10:00 PM